← Back
$TARA All transactions

Protara Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$119K

Shares

22,598

Price

$5

Filed

Apr 2

Insider

Name

Zummo Jacqueline

Title

Chief R&D Officer

CIK

0001798929

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

95,961

Footnotes

The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.31, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Filing Info

Accession No.

0001213900-26-039328

Form Type

4

Issuer CIK

0001359931

Zummo Jacqueline's History

Date Ticker Type Value
2026-04-08 TARA $6K
2026-04-01 TARA $119K

Other Insiders at TARA (90d)

Insider Bought Sold Last
Zummo Jacqueline
Chief R&D Officer
$6K 2026-04-08